Clinical Trial Update: Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ixazomib, lenalidomide, and dexamethasone in smoldering multiple myeloma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoldering Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• NINLARO (ixazomib)
• Revlimid (lenalidomide)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Smoldering Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2025-03-05